Page last updated: 2024-10-29

ketoconazole and Pelvic Inflammatory Disease

ketoconazole has been researched along with Pelvic Inflammatory Disease in 1 studies

1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.

Pelvic Inflammatory Disease: A spectrum of inflammation involving the female upper genital tract and the supporting tissues. It is usually caused by an ascending infection of organisms from the endocervix. Infection may be confined to the uterus (ENDOMETRITIS), the FALLOPIAN TUBES; (SALPINGITIS); the ovaries (OOPHORITIS), the supporting ligaments (PARAMETRITIS), or may involve several of the above uterine appendages. Such inflammation can lead to functional impairment and infertility.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Garamvölgyi, G1
Pajor, A1
Lintner, F1

Other Studies

1 other study available for ketoconazole and Pelvic Inflammatory Disease

ArticleYear
Importance of oral ketoconazole in family planning especially in women using intra-uterine device.
    Therapia Hungarica (English edition), 1988, Volume: 36, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Candidiasis, Vulvovaginal; Contraceptives, Oral; Family Pla

1988